Elon Musk’s brain implant firm Neuralink wins approval for human trials
Brain-computer interface company Neuralink announced May 25 that it has received US Food and Drug Administration (FDA) approval for a human clinical study.
Neuralink did the ad on twitter: “We are pleased to share that we have received FDA approval to launch our first human clinical study.” The tweet said that the approval “represents an important first step that will one day allow our technology to help many people.”
The firm also said the recruitment is not yet open for trial, and it has yet to elaborate on what the trial will entail.
What is Neurallink?
Neuralink was formed in 2016 by Elon Musk and a group of scientists and engineers with the ultimate goal of creating devices that interface with the human brain, both to read information from neurons and to send information directly to the brain. So far, the venture has had mixed success.
In 2020, Musk publicly demonstrated Neuralink’s brain-computer interface prototype for the first time. The prototype was in the shape of a coin with wires attached to one side. The circular part is embedded in the skull and the wires sit a few millimeters on the surface of the brain.
As part of that announcement, the Neuralink team showed a pig that had the device implanted to monitor neurons in its snout, producing signals when the animal touched its snout with food or the ground, and another that was he had safely implanted the device and then had it removed. . A year later, the company showed how a monkey could play the classic video game. Stink using your device. The company came under fire after some monkeys in the tests died and reports surfaced that others were treated poorly.
Research labs have used similar devices to detect and process brain signals to help paralyzed people walk again, develop a mind-controlled wheelchair, and allow people with locked-in syndrome to communicate.
Neuralink did not immediately respond to new scientistrequest for comments.